Home / Business / Healthcare & Pharmaceutical Tools: Save | Print | E-mail | Most Read | Comment
Bayer sets up first R&D center in China
Adjust font size:

Bayer, a leading healthcare product manufacturer, said today it will invest up to 100 million euros ($129.22 million) in the coming five years to establish a research and development (R&D) center in Beijing, the company's first in Asia.

The proposed Beijing center, Bayer's fourth worldwide, will concentrate on developing new drugs with properties that are particular suitable for treating Asian patients. The company said it plans to conduct some research and development work at the Beijing center in partnership with Tsinghua University.

Bayer has two R&D centers in Germany and one in the United States.

Bayer's sales in China, its third largest market, ranks at the top among international health care companies.

(China Daily February 12, 2009)

Tools: Save | Print | E-mail | Most Read
Pet Name
China Archives
Related >>
- Bayer lets off great chance to go top
- Environmental protection a highlight of Bayer
- Bayer's China sales hit US$2.76b
- Extra time for Topsun, Bayer
- Bayer knock out Sparta to enter UEFA Cup next round

Feb.14, Beijing China Macro-Economy Forecast Spring Annual Conference
Feb.22 - Feb.23, Shenzhen 21st Century China Capital Market Annual Conference
Feb.26 Shenzhen Time Weekly Marketing Awarding Ceremony

- Output of Major Industrial Products
- Investment by Various Sectors
- Foreign Direct Investment by Country or Region
- National Price Index
- Value of Major Commodity Import
- Money Supply
- Exchange Rate and Foreign Exchange Reserve
- What does the China-Pakistan Free Trade Agreement cover?
- How to Set up a Foreign Capital Enterprise in China?
- How Does the VAT Works in China?
- How Much RMB or Foreign Currency Can Be Physically Carried Out of or Into China?
- What Is the Electrical Fitting in China?